We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,
Australasia,Asia,Middle East,Africa
Monthly Production Capacity: hundreds of grams
Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag
Delivery Lead Time: In stock or 2-3weeks
Sample Provided: yes
Payment Terms: T/T
Defensins can not only directly resist pathogenic microorganisms, but also have immunomodulatory effects. Defensin enhances the activity and chemotaxis of non-specific immune cells, especially macrophages, through cell signaling. Defensins can also promote the chemotaxis and proliferation of the body's T cells, enhance the body's immune response capabilities, regulate specific immunity, and enhance the biological body's active defense function. The defensin has a broad antibacterial spectrum, a special mechanism of action, and microorganisms should not develop resistance, so it has great medicinal potential. The defensin achieves the purpose of sterilization by directly targeting the bacterial cell membrane, and does not produce drug resistance, so it is expected to solve the increasing problem of bacterial drug resistance. ALPHA-DEFENSIN-3 (HUMAN) contains three pairs of localized disulfide bond structures, consisting of 30 amino acids. The sequence contains a certain number of basic amino acids, but the hydrophilicity is not good.
Audited Supplier
Pharma Sources Insight JANUARY 2024
